Penns Woods Bancorp (NASDAQ:PWOD) reported quarterly earnings of $0.74 per share. This is a 27.59 percent increase over earnings of $0.58 per share from the same period last year.
Amgen Highlights First And Only Randomized, Double-blind, Head-To-head Study Comparing Aimovig (erenumab-aooe), An Anti-CGRP Pathway Therapy, To Topiramate Published In Cephalalgia
Amgen (NASDAQ:AMGN) today announced new data from the HER-MES study, the first and only head-to-head study of Aimovig® (erenumab-aooe), a calcitonin gene-related peptide (CGRP) inhibitor, against topiramate for
